Matinas BioPharma Holdings, Inc.
MTNB
$0.18
$0.00-0.87%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.33M | -1.92M | -1.91M | -1.53M | -5.25M |
| Total Depreciation and Amortization | 4.00K | 74.00K | 95.00K | 111.00K | 122.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -126.00K | 113.00K | 531.00K | 253.00K | 3.58M |
| Change in Net Operating Assets | -388.00K | 133.00K | -223.00K | -306.00K | -481.00K |
| Cash from Operations | -1.84M | -1.60M | -1.51M | -1.47M | -2.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 15.00K | 320.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 15.00K | 320.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00K | -- | -7.00K | 0.00 | -1.00K |
| Issuance of Common Stock | -- | -- | 65.00K | 64.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 1.65M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -27.00K |
| Cash from Financing | -1.00K | -- | 58.00K | 64.00K | 1.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.84M | -1.60M | -1.44M | -1.09M | -399.00K |